Transcode Therapeutics ROIC

Return on Invested Capital (ROIC) of Transcode Therapeutics is 831.51 % in 2026.

Return on Invested Capital (ROIC) of Transcode Therapeutics changed from -1,130.17 % to 831.51 %, representing a -173.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Invested Capital (ROIC) Transcode Therapeutics since 2006 – with annual values, charts, and detailed analysis.

ROIC measures how effectively a company uses its invested capital to generate profits. A ROIC above the cost of capital creates shareholder value.

ROIC = NOPAT / Invested Capital

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Invested Capital (ROIC)'s Transcode Therapeutics with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Invested Capital (ROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Invested Capital (ROIC).